Clinical Trial Update: Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients

View source ↗

Summary

Clinical trial update on a multiparametric prognostic and predictive system to classify patients with neuroendocrine neoplasms grade 3 (NET G3). Sponsored by th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Neuroendocrine Tumor

Snippet

Sponsor: European Institute of Oncology | Conditions: Neuroendocrine Neoplasm | Status: RECRUITING